GlassScriptPhysician profile
Elia Quiroga
NPI 1093759532
$2,515.66
in general payments reported to CMS, 2019-2025
22 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $449 · 2022: $801 · 2023: $389 · 2024: $688 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $385.54 | 2021-2023 | Nucala |
| Amgen INC. | $269.85 | 2021-2025 | Evenity, Tezspire, Uplizna |
| Astrazeneca Pharmaceuticals LP | $226.40 | 2021-2024 | Fasenra, Saphnelo |
| Lundbeck LLC | $212.28 | 2022-2024 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $154.74 | 2023-2024 | Glassia, Hyqvia |
| Lilly USA, LLC | $153.38 | 2024 | Omvoh |
| Abbvie INC. | $147.54 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $124.99 | 2022 | |
| Horizon Therapeutics Plc | $124.97 | 2022 | |
| Spr Therapeutics, INC | $119.08 | 2025 | Sprint Pns System |
| Alexion Pharmaceuticals, INC. | $113.53 | 2021 | |
| Sanofi-Aventis U.S. LLC | $103.31 | 2024 | |
| Tg Therapeutics, INC. | $97.54 | 2024 | |
| Daiichi Sankyo INC. | $72.11 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $51.42 | 2021-2024 | Monoferric |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $35.56 | 2024-2025 | |
| Argenx US, INC. | $29.50 | 2024 | Vyvgart Hytrulo |
| Pfizer INC. | $28.35 | 2021 | |
| Tersera Therapeutics LLC | $20.06 | 2023 | Quzyttir |
| Genzyme Corporation | $16.61 | 2022 | |
| Janssen Biotech, INC. | $15.97 | 2024 | Stelara |
| Biogen, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elia Quiroga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.